AKBA
Akebia Therapeutics, Inc. · Healthcare
SVP and Chief Business Officer Michel Dahan sold $75K of Akebia Therapeutics, Inc.
Sold$75,000
$15.00Price
5,000Shares
−5%Stake
What AKBA did after the filing
Prices for AKBA after this filing aren't in yet.
Traded Tue, Aug 15. Filed Thu, Aug 17, 12:06 PM ET, during the session. Not investment advice.